SCHEMBL18481207

SCHEMBL18481207

Nc1ncnn2c([C@@H]3O[C@H](CO)C(O)C(F)C3Cl)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.39
▸ ADORA3 P0DMS8 3/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ PDE2A O00408 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ HIF1A Q16665 2/20 0.36
▸ DOT1L Q8TEK3 3/20 0.35
▸ GAPDH P04406 2/20 0.35
▸ DPP4 P27487 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ SLC28A1 O00337 1/20 0.35
▸ MAP3K7 O43318 1/20 0.35
▸ SLC28A2 O43868 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ STAT6 P42226 1/20 0.35
▸ PI4KA P42356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19101901 0.92 POLRMT (0.40) POLRMTADORA3ADORA2AADORA1PDE2A
SCHEMBL16479516 0.92 POLRMT (0.40) POLRMTADORA3ADORA2AADORA1PDE2A
SCHEMBL806951 0.92 POLRMT (0.40) POLRMTADORA3ADORA2AADORA1PDE2A
SCHEMBL19101808 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL10154369 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL24982409 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL16710417 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL25008855 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL24982322 0.86 HIF1A (0.46) POLRMTADORA3ADORA2AADORA1HIF1A
SCHEMBL881562 0.83 POLRMT (0.40) POLRMTADORA3ADORA2AADORA1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037078-A1 2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER COCRYSTAL PHARMA, INC. (US) 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037078-A1 2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER HAVCR2, HCCS, NAMPT POLRMT 962/4885ADORA3 330/4885ADORA2A 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback